By extending this computational analysis to other histamine H1 receptor antagonists, we identified six additional compounds—including cyproheptadine—that share AQVN/EIIP characteristics with carbinoxamine, which was previously reported to have anti-influenza activity. The gene discussed is HRH1; the disease is influenza.